Johnson and Johnson 2013 Annual Report Download - page 33

Download and view the complete annual report

Please find page 33 of the 2013 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 84

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84

JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
(Dollars in Millions) (Note 1)
Total
Retained
Earnings
Accumulated
Other
Comprehensive
Income
Common Stock
Issued Amount
Treasury
Stock
Amount
Balance, January 2, 2011 $56,579 77,773 (3,531) 3,120 (20,783)
Net earnings attributable to Johnson & Johnson 9,672 9,672
Cash dividends paid (6,156) (6,156)
Employee compensation and stock option plans 1,760 111 1,649
Repurchase of common stock (2,525) (2,525)
Other (149) (149)
Other comprehensive income, net of tax (2,101) (2,101)
Balance, January 1, 2012 $57,080 81,251 (5,632) 3,120 (21,659)
Net earnings attributable to Johnson & Johnson 10,853 10,853
Cash dividends paid (6,614) (6,614)
Employee compensation and stock option plans 3,269 19 3,250
Issuance of common stock associated with the
acquisition of Synthes, Inc. 13,335 483 12,852
Repurchase of common stock(1) (12,919) (12,919)
Other comprehensive income, net of tax (178) (178)
Balance, December 30, 2012 $64,826 85,992 (5,810) 3,120 (18,476)
Net earnings attributable to Johnson & Johnson 13,831 13,831
Cash dividends paid (7,286) (7,286)
Employee compensation and stock option plans 3,285 (82) 3,367
Repurchase of common stock (3,538) (2,947) (591)
Other (15) (15)
Other comprehensive income, net of tax 2,950 2,950
Balance, December 29, 2013 $74,053 89,493 (2,860) 3,120 (15,700)
(1) Includes repurchase of common stock associated with the acquisition of Synthes, Inc.
See Notes to Consolidated Financial Statements
Johnson & Johnson 2013 Annual Report •23